Lisa Ferrin
Adult Health · Indianapolis, INNPI 1841475852
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,641, more than ten times the $101 reported in 2021. Among adult health clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$886
- Alkermes, Inc.$518
- Otsuka America Pharmaceutical, Inc.$514
- Lundbeck LLC$320
- Neurocrine Biosciences, Inc.$313
- Axsome Therapeutics, Inc.$278
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,728100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 65 | $886 |
| Alkermes, Inc. | 31 | $518 |
| Otsuka America Pharmaceutical, Inc. | 38 | $514 |
| Lundbeck LLC | 19 | $320 |
| Neurocrine Biosciences, Inc. | 20 | $313 |
| Axsome Therapeutics, Inc. | 10 | $278 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $252 |
| Sumitomo Pharma America, Inc. | 11 | $237 |
| Jazz Pharmaceuticals Inc. | 11 | $186 |
| Indivior Inc. | 8 | $172 |
| AbbVie | 9 | $155 |
| Corium, LLC | 7 | $120 |
| Johnson & Johnson | 8 | $115 |
| Noven Therapeutics, LLC | 6 | $110 |
| Harmony Biosciences LLC | 2 | $74 |
| Sunovion Pharmaceuticals Inc. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Almatica Pharma LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Kerecis Limited | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Hartmann USA, Inc. | 1 | $26 |
| Bioxcel Therapeutics, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| USWM, LLC | 1 | $16 |
How this compares
$4,728 in reported general payments places this provider in the 90th percentile of 391 adult health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Indianapolis
- Jennifer BerryIndianapolis$50K
- Alison LaflowerIndianapolis$13K
- Megan WeaverIndianapolis$11K
- Lorraine CalvertIndianapolis$8K
- Barbara BowersIndianapolis$7K
- Kendra StorerIndianapolis$7K
- Jeffrey LaneIndianapolis$6K
- David NolteIndianapolis$5K
- Pamela AndersonIndianapolis$4K
- Lonna WilliamsIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.